Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis.
Ebell MH, Barry HC, Baduni K, Grasso G.
Ann Fam Med. 2024 Jan-Feb;22(1):50-62. doi: 10.1370/afm.3050.
PMID:38253509
Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Regnault A, Boroojerdi B, Meunier J, Bani M, Morel T, Cano S.
J Neurol. 2019 Aug;266(8):1927-1936. doi: 10.1007/s00415-019-09348-3. Epub 2019 May 9.
PMID:31073716
Mini-Mental State Examination in Elderly Chinese: A Population-Based Normative Study.
Li H, Jia J, Yang Z.
J Alzheimers Dis. 2016 May 7;53(2):487-96. doi: 10.3233/JAD-160119.
PMID:27163822
Performance of Mattis dementia rating scale-Chinese version in patients with mild cognitive impairment and Alzheimer's disease.